Common Equity: The sum of all common equity items.
Palisade Bio, Inc. (PALI) had Common Equity of $129.38M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-16.78M |
|
-- |
|
-- |
|
$18.06M |
|
$-18.06M |
|
$1.27M |
|
$-16.78M |
|
$-16.78M |
|
$-16.78M |
|
$-16.78M |
|
$-16.78M |
|
$-16.78M |
|
$-18.06M |
|
$-18.05M |
|
55.67M |
|
55.67M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$134.22M |
|
-- |
|
$0.12M |
|
$134.34M |
|
$4.64M |
|
-- |
|
$0.33M |
|
$4.96M |
|
|
Common Equity |
$129.38M |
$129.38M |
|
$129.38M |
|
159.44M |
|
| Cash Flow Statement Financials | |
$-10.85M |
|
-- |
|
$134.44M |
|
$9.85M |
|
$133.44M |
|
$123.59M |
|
$3.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.95 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.97% |
|
-12.97% |
|
-12.49% |
|
-12.97% |
|
$0.81 |
|
$-0.19 |
|
$-0.19 |
|